Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Strong specialty pharma growth is expected to continue through 2027, driven by focused investments in oncology and retina, integration of MSO platforms, and robust international performance. Regulatory and customer dynamics are being managed proactively, with capital allocation priorities unchanged…
Strong specialty-driven growth continues, with confidence in long-term momentum through 2027. Integration of OneOncology and RCA enhances clinical trial capabilities, while regulatory and customer dynamics remain well managed. Capital deployment focuses on growth, M&A, and shareholder returns.Based…